» Articles » PMID: 25755633

Truncated Tau Deregulates Synaptic Markers in Rat Model for Human Tauopathy

Overview
Specialty Cell Biology
Date 2015 Mar 11
PMID 25755633
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Synaptic failure and neurofibrillary degeneration are two major neuropathological substrates of cognitive dysfunction in Alzheimer's disease (AD). Only a few studies have demonstrated a direct relationship between these two AD hallmarks. To investigate tau mediated synaptic injury we used rat model of tauopathy that develops extensive neurofibrillary pathology in the cortex. Using fractionation of cortical synapses, we identified an increase in endogenous rat tau isoforms in presynaptic compartment, and their mis-sorting to the postsynaptic density (PSD). Truncated transgenic tau was distributed in both compartments exhibiting specific phospho-pattern that was characteristic for each synaptic compartment. In the presynaptic compartment, truncated tau was associated with impairment of dynamic stability of microtubules which could be responsible for reduction of synaptic vesicles. In the PSD, truncated tau lowered the levels of neurofilaments. Truncated tau also significantly decreased the synaptic levels of Aβ40 but not Aβ42. These data show that truncated tau differentially deregulates synaptic proteome in pre- and postsynaptic compartments. Importantly, we show that alteration of Aβ can arise downstream of truncated tau pathology.

Citing Articles

Tau truncation in the pathogenesis of Alzheimer's disease: a narrative review.

Chu D, Yang X, Wang J, Zhou Y, Gu J, Miao J Neural Regen Res. 2023; 19(6):1221-1232.

PMID: 37905868 PMC: 11467920. DOI: 10.4103/1673-5374.385853.


Pathological Impact of Tau Proteolytical Process on Neuronal and Mitochondrial Function: a Crucial Role in Alzheimer's Disease.

Olesen M, Quintanilla R Mol Neurobiol. 2023; 60(10):5691-5707.

PMID: 37332018 DOI: 10.1007/s12035-023-03434-4.


Activity-dependent tau cleavage by caspase-3 promotes neuronal dysfunction and synaptotoxicity.

Opland C, Bryan M, Harris B, McGillion-Moore J, Tian X, Chen Y iScience. 2023; 26(6):106905.

PMID: 37305696 PMC: 10251131. DOI: 10.1016/j.isci.2023.106905.


Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.

Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy P Int J Mol Sci. 2022; 23(21).

PMID: 36361631 PMC: 9654278. DOI: 10.3390/ijms232112841.


Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy.

Mate V, Smolek T, Kazmerova Z, Jadhav S, Brezovakova V, Jurkanin B Front Aging Neurosci. 2022; 14:935973.

PMID: 35966785 PMC: 9363241. DOI: 10.3389/fnagi.2022.935973.


References
1.
Tannenberg R, Scott H, Tannenberg A, Dodd P . Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4. Neurochem Int. 2006; 49(7):631-9. DOI: 10.1016/j.neuint.2006.05.004. View

2.
Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

3.
Augustinack J, Schneider A, Mandelkow E, Hyman B . Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol. 2002; 103(1):26-35. DOI: 10.1007/s004010100423. View

4.
Verhey K, Gaertig J . The tubulin code. Cell Cycle. 2007; 6(17):2152-60. DOI: 10.4161/cc.6.17.4633. View

5.
Mondragon-Rodriguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N . Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J Biol Chem. 2012; 287(38):32040-53. PMC: 3442535. DOI: 10.1074/jbc.M112.401240. View